Award winning scientist and Managing Director of SYNthesis BioVentures Andrew Wilks tells James Willis how Australia's growing biotech sector is at risk of being stifled due to the government's CGT changes.

Money News with James Willis 💵📊📻 - Thursday, 30th July
38:45

"Bizarre... stupidity... crazy": Chalmers' tax grab slammed
11:27

Money News with James Willis 💵📊📻 - Wednesday, 29th July
38:40